-
-
-
-
-
-
-
Wave Life Sciences plans redomiciliation from Singapore to Delaware
-
-
-
-
-
-
-
Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RN
-
-
-
-
-
-
-
Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
WAVE Life Sciences (WVE) Misses Q2 EPS by 4c
-
-
-
-
-
-
-
Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Wave Life Sciences Second Quarter 2023 Financial Results Scheduled for August 3, 2023
-
-
-
-
-
-
-
Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
1,208,396 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

